Increased tissue stiffness is a driver of breast cancer progression. The transcriptional regulator YAP is considered a universal mechanotransducer, based largely on 2D culture studies. 14 However, the role of YAP during in vivo breast cancer remains unclear. Here, we find that mechanotransduction occurs independently of YAP in breast cancer patient samples and 16 mechanically tunable 3D cultures. Mechanistically, the lack of YAP activity in 3D culture and in vivo is associated with the absence of stress fibers and an order of magnitude decrease in nuclear 18 cross-sectional area relative to 2D culture. This work highlights the context-dependent role of YAP in mechanotransduction, and establishes that YAP does not mediate mechanotransduction 20 in breast cancer.
B (LepB) showed strong YAP nuclear localization, similar to that of cells seeded on stiff 2D col-76 coated PAM gels, demonstrating that 3D cultured MCF10A cells are competent for YAP activation (Fig. 2C, D) . 78 We explored the possibility that YAP activation requires a higher range of stiffness. Although 1-2 kPa stiff hydrogels are sufficient to induce proliferation and invasion ( fig. S3 ) and 80 are physiologically relevant for malignant mammary tissue (4, 5) , we generated 20 kPa hydrogels, an order of magnitude stiffer than malignant mammary tissue. 20 kPa gels similarly 82 failed to induce nuclear localization of YAP in MCF10A cells ( fig. S6A, B) . Additionally, increasingly malignant MEC lines, MCF10AT and MCF10CA1a (26), and preformed acinar 84 structures transplanted into stiff hydrogels also did not display increased YAP nuclear localization ( fig. S6C-D) . 86 In addition to examining YAP localization, we assessed YAP activity through analysis of YAP phosphorylation and gene expression. Western blot (WB) analysis of cells harvested from 88 soft and stiff IPNs showed similar levels of YAP S127 phosphorylation, a mark of cytoplasmic retention and thus inactivity ( Fig. 2E ). RNA-seq was next performed to assay expression of YAP 90 transcriptional targets, using the YAP target gene list used to identify YAP as a mechanotransducer in 2D culture (table S1) (13). In agreement with IF results, expression of 92 YAP target genes did not trend with increased stiffness ( Fig. 2F ; see also table S1) or col-1 density ( fig. S7A ). Notably, expression of canonical YAP target genes ANKRD1, CTGF, 94 CYR61, ITGB2 were not differentially regulated by enhanced stiffness (Fig. 2G ) or col-1 density ( fig. S7B ). This is in contrast to the robust YAP activation and target gene expression 96 demonstrated by the same MEC line in 2D culture ( fig. S8 ) (27) . Given the surprising lack of YAP activation by increased 3D culture stiffness, we 98 generated doxycycline (dox)-inducible CRISPR/Cas9 YAP knockout (ΔYAP) MCF10A cells to test the dispensability of YAP in mechanotransduction. As absence of YAP may impact cell 100 growth in 2D culture prior to encapsulation, cells stably expressing dox-inducible Cas9 and sgRNA targeting YAP (MCF10A::Cas9/sgYAP) were first encapsulated in 3D culture without 102 Cas9 induction. Following encapsulation, cells were treated with dox to induce Cas9 expression and sgRNA-directed editing. Dox treated MCF10A::Cas9/sgYAP cells showed depletion of YAP 104 protein compared to untreated and MCF10A::Cas9/sgGAL4 controls ( Fig. 2H ). As Cas9 induction results in a mixed population of KO cells, only cells verified for ΔYAP by IF were 106 assayed for mechanotransduction ( Fig. 3I ). Interestingly, ΔYAP cells did not reduce stiffnessinduced invasion (Fig. 2J ) or proliferation ( Fig. 2K ) compared to ΔGAL4 controls. As YAP did 108 not regulate mechanotransduction during breast cancer progression, we explored other transcriptional regulators that target genes identified by RNA-seq to be modulated by stiffness 110 ( fig. S9-11 ). Bioinformatics, small molecule inhibitor, inducible CRISPR/Cas9 KO, and overexpression experiments strongly implicate STAT3 and p300 as mechanotransducers during 112 breast cancer ( fig. S9 and S10). Taken together, our analyses of YAP and TAZ nuclear localization, YAP phosphorylation state, expression of YAP target genes, and inducible 114 CRISPR/Cas9 knockout cells conclusively show that YAP does not mediate mechanotransduction in 3D culture. 116 To assess the relevance of this 3D culture model to DCIS, we compared our RNA-seq data of cells encapsulated in soft or stiff IPNs (Fig. 2F ) to 3SEQ data from normal and DCIS 118 patient samples (28) (Fig. 2F, G) . Importantly, a set of genes was identified that showed similar regulation in stiff IPNs as DCIS samples ( Fig. 2L the most highly upregulated target from  124 stiff IPNs, S100A7, as the most relevant stiffness-regulated gene in DCIS ( Fig. 5L ). S100A7 has been implicated in DCIS with roles in proliferation and apoptosis-resistance, and tumor-126 associated immune cell recruitment (29-31). RNA-seq results were confirmed by WB analysis of S100A7 in cells harvested from soft and stiff IPNs (Fig. 2M ), IHC of S100A7 in breast cancer 128 patient tissues (Fig. 2N ), and qPCR of cells harvested from soft and stiff IPNs ( fig. S12 ).
Together, these results demonstrate that 3D culture of MECs in stiff IPNs is highly relevant to 130 modeling DCIS, and provides a gene signature of stiffness-induced carcinoma progression.
To elucidate the mechanism underlying the confounding result that YAP is responsible 132 for mechanotransduction in 2D, but not 3D culture nor primary tissue, we examined nuclear morphologies. This analysis was motivated by the recent finding that stiffness-induced YAP 134 activation requires nuclear flattening-mediated opening of nuclear pores (15, 16) . Analysis of nuclear morphologies showed drastic differences in DCIS primary tissues and cells in 3D culture 136 compared to 2D culture ( Fig. 3A) . Strikingly, nuclear area in cells from 2D culture show a tenfold increase in cross-sectional area compared to 3D culture and patient samples ( Fig. 3B) . A 138 three-fold increase in nuclear perimeter was also observed ( Fig. 3C ), in addition to a significant increase in solidity, a measure of the "smooth" nature of the perimeter (fig. S13A). During 140 progression from normal to DCIS to IDC, patient samples showed interesting, but comparatively small, differences in nuclear morphology ( Fig. S13B-E ). 142
Notably, YAP nuclear intensity scales with nuclear area, with nuclei from patient samples and 3D culture deviating from the size range observed for positive nuclear YAP intensity ( Fig.  144 3D). Similarly, nuclear YAP intensity scales with nuclear perimeter (Fig. 3E ). Positive nuclear YAP intensity also correlated with high solidity, which is almost exclusively observed in nuclei 146 from 2D culture ( Fig. S13F ). However, some nuclei from soft 2D PAM reach the required size ranges but fail to show positive nuclear YAP intensity, suggesting that nuclear morphology is not 148 the only factor required for YAP activation. As nuclear morphologies and YAP activation in 2D culture has been linked to stress fiber 150 contractility, we investigated the role of stress fibers in 3D culture. Recent studies showed mechanical coupling of stiff ECM to the nucleus through stress fibers, with fiber contractility 152 causing nuclear flattening and subsequent nuclear pore stretching (15, 16) . Further, the enrichment of perinuclear stress fibers was required for YAP nuclear translocation in 2D culture 154 (16). To examine if stress fibers contribute to the observed changes in nuclear morphology, we assayed stress fibers in cells cultured in 2D and 3D. The presence of robust perinuclear stress 156 fibers was observed in cells cultured on stiff PAM gels, in which nuclear localization of YAP was observed, but not soft PAM gels nor stiff or soft IPNs, in which nuclear localization of YAP 158
was not observed (Fig. 3F , G). This is in agreement with previous reports that cells cultured in 3D substrates fail to form robust stress fibers (32, 33), and instead adopt a predominantly cortical 160 F-actin architecture (Fig. 3G ). This suggests a model where the presence of perinuclear stress fibers, coupled with distinct nuclear morphologies, is the basis of differences between YAP 2D 162 and 3D activation ( Fig. 3H ).
In this study, we examined the role of YAP in mediating mechanotransduction during 164 ductal carcinoma progression using patient samples and 3D culture models. Cancer has historically been thought of as a genetic disease, with tumors arising from genetic mutations in 166 DNA. However, it has been increasingly recognized that the microenvironment plays a key role in regulating cancer progression. Our study provides compelling evidence that 2D YAP 168 mechanotransduction studies do not recapitulate the conditions seen in clinical samples, and suggests a critical need for the use of 3D culture models in studying breast cancer. Finally, our 170 findings also reveal new therapeutics targets, including STAT3 and p300, for blocking invasion in breast cancer. 172
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Materials and Methods 348
Step-by-step protocols can be accessed at The Chaudhuri Lab's bio-protocol website: https://en. NaOH, and pH adjusted with 0.1 N HCl. rBM and col were mixed with cells and DMEM/F12 to the reach the indicated final concentrations. MCF10A cells were trypsinized, strained through a 422 40 µm cell strainer to enrich for single cells, counted on a Vi-CELL (Beckman Coulter Life Sciences), and seeded at a final concentration of 1 x 10 5 cells/ml hydrogel. Hydrogel-cell 424 mixtures were quickly deposited into wells of a 24-well plate pre-coated with 50 µl gelled rBM. Hydrogels containing cells were placed in a 37°C incubator with CO 2 to gel for 30 min before a 426 transwell insert (Millipore) was placed on top to prevent floating and 1.5 ml complete medium added. 428 IPNs were formed as described (2). Briefly, LF20/40 alginate (FMC Biopolymer) was solubilized, dialyzed, charcoal filtered, sterile filtered, lyophilized, and reconstituted to 2.5% w/v 430 in DMEM/F12. Alginate was mixed with rBM, cells, and DMEM/F12 and loaded into a 1 ml Luer lock syringe (Cole-Parmer), on ice. For crosslinking, a second 1 ml syringe was loaded with 432 125 mM CaSO 4 or DMEM/F12, on ice. Syringes were connected with a female-female Luer lock coupler (ValuePlastics), rapidly mixed with 4-6 pumps of the syringes handles back and forth, 434
and quickly deposited into pre-coated wells, as above. IPNs containing cells were allowed to gel before adding transwell filters and medium, as above. 436
For 20 kPa alginate-RGD hydrogels, alginate-RGD hydrogels were prepared as described previously (3) . Briefly, LF20/40 alginate (FMC Biopolymer) was dialyzed, filtered and 438 lyophilized, and then was coupled to RGD oligopeptide GGGGRGDSP (Peptide 2.0) using carbodiimide chemistry (4) . The final density of RGD in the alginate hydrogel was matched as 440 150 mM RGD in a 2% wt/vol alginate gel. The modified alginate was dialyzed, charcoal filtered, sterile filtered and lyophilized again. Alginate-RGD was reconstituted to 2.5% w/v in 442 DMEM/F12 and mixed with MCF10A cells. The cell-alginate solution was then mixed with DMEM/F12 containing 24.4 mM CaSO 4 , and then deposited between two glass plates spaced 2 444 mm apart. The cell-alginate mixture was allowed to gel for 45 minutes, and then disks of hydrogel were punched out and immersed in complete growth medium. 446
For 2D PAM gels, the surface of coverslips was functionalized accoring to a previous method (5) . Coverslips were cleaned with ethanol, immersed in 0.5% Aminopropyl)trimethoxysilane (in dH 2 O) at room temperature for 30 min and washed with dH 2 O. Coverslips were then immersed in 0.5% glutaraldehyde in dH 2 O at room temperature for 450 30 min and dried. A prepolymer solution was prepared containing acrylamide, N,N′-methylenebis-acrylamide, 1/100 volume of 10% Ammonium Persulfate (APS), and 1/1000 volume of 452 N,N,N',N'-Tetramethylethylenediamine (TEMED). The final concentration of acrylamide and bis-acrylamide was varied to control substrate stiffness (6) . For 0.1 kPa hydrogels, 3% /0.02% 454 were used. For 1 kPa hydrogels, 3% /0.1% were used. For 2 kPa hydrogels, 4% /0.1% were used. Prepolymer solutions were deposited on a Sigmacote-treated hydrophobic glass plate, and 456 functionalized coverslips placed on top of the prepolymer solution. Polyacrylamide solutions were allowed to polymerize for 30 minutes between the hydrophobic glass plate and the 458 functionalized coverslip. When polymerization was completed, polyacrylamide gels were carefully separated from the glass plate. 460
To enable cell adhesion to the PAM gel, col-1 and rBM were conjugated to the gel surface using sulfosuccinimidyl 6-(4'-azido-2'-nitrophenylamino)hexanoate (sulfo-SANPAH) as 462 a protein-substrate linker. PAM gels were incubated in 1 mg/ml sulfo-SANPAH in 50 mM HEPES pH 8.5, activated with UV light (wavelength 365 nm, intensity 4mW/cm 2 ) for 20 min, 464 washed in HEPES, and then incubated in 100 ug/ml col-1 and rBM in HEPES overnight at room temperature. The protein-crosslinked PAM gels were washed with PBS before use. 466
Mechanical Testing 468
Stiffness measurements of 3D culture rBM, col, and IPN hydrogels were performed using an AR-G2 stress-controlled rheometer with 25-mm top-and bottom-plate stainless steel 470 geometries (TA Instruments). Hydrogel solutions without cells were mixed and immediately deposited onto the bottom plate of the rheometer and the top plate lowered such that the gel 472 formed a uniform disk between the two plates. Exposed hydrogel surfaces were coated with mineral oil (Sigma) and covered with a hydration chamber to prevent sample dehydration. The 474 storage modulus was monitored at 37°C with 1% strain at a frequency of 1 Hz and measurements taken once the storage modulus reached an equilibrium value. The storage and loss moduli were 476 then used to calculate the Young's modulus (E). Young's moduli (i.e. elastic moduli) were calculated using the equation E = 2G* × (1 + v), where v is Poisson's ratio, assumed to be 0.5, 478 and G* is the bulk modulus calculated using the equation G* = (G' 2 + G'' 2 ) 1/2 where G' 2 is the storage and G'' 2 is the loss modulus. 480
To measure substrate stiffness of 2D PAM gels, unconfined compression tests were performed using an Instron MicroTester 5848. PAM gels were compressed at a rate of 1 482 mm/min. The tangent elastic modulus of the measured stress-strain curves was calculated between 5%-15% strain (7, 8). Stiffness of 3D culture alginate hydrogels was measured using 484 unconfined compression tests according to a previously published method (3). Briefly, alginate disks (15 mm in diameter, 2 mm thick) were submerged in DMEM for 1 day to fully equilibrate. 486
The gel disks were compressed to 15% at a rate of 1 mm/min and the slope of the stress-strain curve from 5% to 10% strain was used to obtain the stiffness of alginate hydrogel. 488
Antibodies 490
Mouse anti-YAP (cat. #sc-101199; Santa Cruz Biotech) was used at 1:200 (IF) and 1:500 (WB), rabbit anti-phospho-YAP (cat. #13008; Cell Signaling Technology) was used at 1:500 for 492 WB. Mouse anti-S100A7 (cat. #sc-377084; Santa Cruz Biotech) was used at 1:500 (WB Phalloidin-Alexa555 (A34055; Thermo Fisher Scientific) was used at 1:100 and DAPI (cat. #D9542; Sigma-Aldrich) was used at 5 µg/ml for IF. 504
For IF, Alexa 488-, 555-or 647-conjugated secondary antibodies (Thermo Fisher Scientific) were used at 1:500. For WB, IRDye 680 or 800-conjugated secondary antibodies (LI-506 COR Biotechnology) were used at 1:10,000. 508
Western blotting and immunoprecipitation MCF10A cells encapsulated for 7 days were harvested from IPNs by incubation in cold 510 PBS containing 50 mM EDTA (Sigma) for 5 min while pipetting to break up gels. Cells were centrifuged at 500 x g for 10 min. The supernatant was removed and the cells with remaining 512 matrix material were treated with 0.25% trypsin (Gibco) for 5 min and centrifuged for 5 min at 500 x g. Cells encapsulated in hydrogels for seven days were fixed for 30 min in 4% paraformaldehyde in DMEM/F12. Gels containing cells were washed with PBS and incubated in 536 30% sucrose in PBS with calcium and magnesium overnight followed by incubation in 50/50 30% sucrose/OCT for 6 h. Gels were embedded in OCT and frozen prior to cutting 40 µm 538 sections using a Microm HM 550 Cryostat. Sections were blocked in PBS-BT+: PBS pH 7.4 (Gibco) supplemented with 1% BSA (Sigma-Aldrich), 0.1% Triton X-100 (Sigma-Aldrich), 0.3 540 M glycine (Sigma-Aldrich), 10% goat serum (Gibco), and 0.05% sodium azide (Sigma-Aldrich). Sections were incubated in primary antibodies diluted in blocking solution as indicated in 542 "antibodies" section for 1 h, and then Alexa 488-, 555-or 647-conjugated secondary antibodies (Thermo Fisher Scientific) diluted 1:500 in blocking solution for 30 min. Sections of gels 544 containing cells were imaged using a Leica TCS SP8 confocal laser scanning microscope (Leica Microsystems, Inc.) with an HC PL APO 63x (1.40 NA Oil CS2) objective. Images were 546 collected from HyD and PMT detectors using LasX software and processed using Photoshop (Adobe Systems). 548
For morphology analyses, ImageJ was used to trace cell clusters and circularity measured using the Measurements function. Circularity, C, was calculated as, C = 4π(A/p 2 ), where A is the 550 area and P is the perimeter. A perfect circle would have a circularity of 1. Solidity was calculated as area enclosed by outer contour of object divided by area enclosed by convex hull of outer 552 contour.
Cell Profiler was used to quantify YAP nuclear/cytoplasmic intensity in IF images. 554
ImageJ was used to trace cell nuclei using DAPI images using the following macro (pixel/µm of image was first determined and replaced in "Set Scale" distance; found pixel/µm of image by 556 drawing line over scale bar embedded in image and using the function Analyze -> Set Scale). Doublets or cell debris were then manually excluded. Nuclear traces were then overlaid on YAP 558 images to measure mean nuclear YAP intensity using the following macro. 560
Macro to trace cell nuclei: run("Set Scale...", "distance=[3.45 ] known=1 pixel=1 unit=µm"); 562 run("Gaussian Blur...", "sigma=2"); run("Subtract Background...", "rolling=50"); 564 setAutoThreshold(); //run("Threshold..."); 566 setAutoThreshold(); setThreshold(55, 255); 568 run("Convert to Mask"); run("Fill Holes"); 570 run("Watershed"); run("Find Edges"); 572 run("Analyze Particles...", "size=100-Infinity pixel circularity=0.00-1.00 show=Nothing exclude add"); 574 close(); 576
Macro to measure nuclear YAP intensity: run("Set Measurements...", "area mean center perimeter bounding shape integrated skewness 578 redirect=None decimal=3"); run("Set Scale...", "distance=[3.45 ] known=1 pixel=1 unit=µm"); 580 setOption("Show All",true); roiManager("Measure"); 582 saveAs("Measurements", "/Users/Joanna/Desktop/Results.xls"); 584
Tissue immunohistochemistry Immunohistochemical (IHC) staining was performed on paraffin-embedded tissue 586 microarray (TMA) sections (Stanford TA419, 445, 424). Anti-S100A7 polyclonal antibody at 1:100 (Millipore-Sigma St. Louis, MO, catalog # HPA006997) was used as primary antibody for 588 IHC staining. Antibody was diluted in PBS. Briefly, 4 µm TMA sections were deparaffinized in 3 changes of xylene for 10 mins each and hydrated in gradient series of ethyl alcohol. Following 590 target retrieval in 10 mM citrate pH6 (Dako/Agilent, Carpinteria, CA, USA, catalog #S2369) to retrieve antigenic sites at 116ºC for 3 minutes. Staining was then performed using the VectaStain 592 ABC anti-rabbit kit (Vector Laboratories Burlingame CA, USA, catalog #PK6101). Diaminobenzidine (DAB) (DAKO/Agilent, Carpinteria, CA, USA, catalog #K3468) was used at 594 room temperature for 10 min for color development. The IHC Profiler macro for ImageJ was used to quantify YAP and S100A7 intensity in IHC samples 78 . 596
RNA extraction and next generation sequencing 598
Gels containing MCF10A cells were frozen in liquid nitrogen, ground, and treated with ice-cold PBS supplemented with 50 mM EDTA to break up IPNs. RNA was harvested using a 600 combination of TRIZOL reagent and GenCatch Total RNA Extraction Kit (Epoch). RNA-seq experiments were performed in biological replicate and cDNA libraries constructed using the 602
TruSeq RNA Library Prep Kit v2. Libraries were sequenced on a single lane of the Illumina Hiseq 2500 platform with 50 bp paired end reads. Following quality assessment via FastQC, 604 adapter and quality trimming was executed with Trim Galore. Reads were subsequently aligned to the hg19 genome assembly via Bowtie2 with ~97% concordant alignment rate in all samples. 606
After filtering for unmapped, low quality, and multi-mapped reads, mapped reads were summarized to gene features by HTSeq. Sequencing depth ranged from 30-42 million post-608 filtered reads. We used DESeq2 to evaluate significant cases of differential expression between a given pairwise comparison. Before adjusting p-values for multiple testing, DESeq2 implements 610 independent filtering using mean expressions of each gene as a filter. Adjusting via the Benjamini & Hochberg method, differentially expressed genes with FDR < 0.05 were called 612 significant. Prior to clustering, we used DESeq2's implementation of regularized logarithm transformation (rlog) to stabilize the variance of genes across samples. Mean expression values 614
were used as input to hierarchical clustering of the differentially expressed genes between soft v. stiff IPN. Gene ontology and TF association analysis using ChIP-seq data from ENCODE was 616 implemented via EnrichR (9). Adjusted p-values, which take into account differing sizes of data sets, are reported. 618
Statistical Analysis 620
Multiple comparisons were conducted with one-way ANOVA followed by Tukey post-hoc comparison and pairwise comparisons performed using Student's t-tests. Bars represent mean ± 622 SEM and symbols represent each experiment (for EdU assays), cell cluster (for invasion assays), patient (for 3SEQ expression), and nucleus (for nuclear morphology assays). For graphs of 624
RNA-seq normalized counts from 3D culture, bars represent mean ± SD and symbols represent each RNA-seq experiment using 2 independent trials. Values with p < 0.05 were considered 626 statistically significant, indicated by **. 628
Data Availability RNA-seq data are stored in GEO with the accession code GSE102506. 3SEQ breast cancer 630 progression data are available as described in the original manuscript (10) . Additional normal mammary and breast cancer datasets generated by the Genotype-Tissue Expression (GTEx) 632 project and The Cancer Genome Atlas (TCGA) project, respectively, are available on the Human Protein Atlas (11, 12) . 634 AMOTL2  CDKN2C DUSP1  GAS2L3  LHFP  SCHIP1  TGFB2  ANKRD1  CENPF  DUT  GAS6  MACF1  SDPR  TGM2  ANLN  COL4A3  ECT2  GGH  MARCKS SERPINE1 THBS1  ARHGAP29 CRIM1  EMP2  GKAP1  MDFIC  SERTAD4 TK1  AXL  CTGF  ETV5  GLIS2  MSRB3  SCAF11  TNNT2  BICC1  CYR61  FGF2  GLS  MYO1C  SGK1  TNS1  BIRC5  DAB2  FLNA  HEXB  NDRG1  SH2D4A  TOP2A  CCRN4L  DDAH1  FSCN1  HMMR  PDLIM2  SHCBP1  TSPAN3  CDC20  ASAP1  FSTL1  AGFG2  PHGDH  SLIT2  CDK6 DLC1 GADD45B ITGB2 PMP22 STMN1 Table S1 . YAP target genes used in Fig. 2F . 798
